卵巢癌细胞系来源外来体的获得及形态特征观察

　　[6]Altieri SL, Khan AN, Tomasi TB. Exosomes from plasmacytoma cells as a tumor vaccine [J]. J Immunother, 2004, 27(4):282303.

　　[7]Wolfers J, Lozier A, Raposo G, et al. Tumorderived exosomes are a source of shared tumor rejection antigens for CTL crosspriming [J]. Nat Med, 2001,7(3):297303.

　　[8]Andre F, Schartz NE, Movassagh M, et al. Malignant effusions and immunogenic tumourderived exosomes [J]. Lancet, 2002, 360(9329):295305.

　　[9]Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigenpresenting vesicles [J]. J Exp Med, 1996,183(3):11611172.

　　[10]Kleijmeer MJ, Ossevoort MA, Van Veen CJH, et al. MHC class Ⅱ compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells [J]. J Immunol, 1995,154(11):57155724.

　　[11]Thery C, Regnault A, Garin J, et al. Molecular characterization of dendritic cellderived exosomes. Selective accumulation of the heat shock protein hsc73 [J]. J Cell Biol, 1999,147(3):599610.

　　[12]Alanese J, Meterissian S, Kontogiannea M, et al. Biologically active Fas antigen and its cognate ligand are expressed on plasma membranederived extracellular vesicles [J]. Blood, 1998, 91(10): 38623874.

　　[13]Raposo G, Tenza D, Mecheri S, et al. Accumulation of major histocompatibility complex class Ⅱ molecules in mast cell secretory granules and their release upon degranulation [J]. Mol Biol Cell, 1997, 8(12): 26312645.

上一页  [1] [2] [3] [4]